Camacho, M.; Bagué, S.; Valero, C.; Holgado, A.; López-Vilaró, L.; Terra, X.; Avilés-Jurado, F.-X.; León, X.
Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy. Int. J. Mol. Sci. 2025, 26, 2451.
https://doi.org/10.3390/ijms26062451
AMA Style
Camacho M, Bagué S, Valero C, Holgado A, López-Vilaró L, Terra X, Avilés-Jurado F-X, León X.
Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy. International Journal of Molecular Sciences. 2025; 26(6):2451.
https://doi.org/10.3390/ijms26062451
Chicago/Turabian Style
Camacho, Mercedes, Silvia Bagué, Cristina Valero, Anna Holgado, Laura López-Vilaró, Ximena Terra, Francesc-Xavier Avilés-Jurado, and Xavier León.
2025. "Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy" International Journal of Molecular Sciences 26, no. 6: 2451.
https://doi.org/10.3390/ijms26062451
APA Style
Camacho, M., Bagué, S., Valero, C., Holgado, A., López-Vilaró, L., Terra, X., Avilés-Jurado, F.-X., & León, X.
(2025). Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy. International Journal of Molecular Sciences, 26(6), 2451.
https://doi.org/10.3390/ijms26062451